Brainstorm Cell COO Setboun to leave company - filing
Brainstorm Cell Therapeutics (NASDAQ:BCLI) disclosed in an SEC filing Wednesday that David Setboun will resign as EVP and COO of the company, effective May 31.
Brainstorm Cell Therapeutics (NASDAQ:BCLI) disclosed in an SEC filing Wednesday that David Setboun will resign as EVP and COO of the company, effective May 31.